Acute-on-chronic liver failure: a retrospective review of cases at a transplantation center in Brazil

Fernando Camargo Fernandes, A. C. Boteon, Giovana Garcia Rossi, Fernanda Marques, Bianca Della-Guardia, Yuri L. Boteon
{"title":"Acute-on-chronic liver failure: a retrospective review of cases at a transplantation center in Brazil","authors":"Fernando Camargo Fernandes, A. C. Boteon, Giovana Garcia Rossi, Fernanda Marques, Bianca Della-Guardia, Yuri L. Boteon","doi":"10.1590/acb392624","DOIUrl":null,"url":null,"abstract":"ABSTRACT Purpose: Acute-on-chronic liver failure (ACLF) is a leading cause of death in cirrhotic patients. This study aims to describe the outcomes of in-patients with ACLF at a liver transplantation (LT) center in Brazil. Methods: Retrospective study analyzing patient data from 2017 to 2022. Re-transplant cases and patients without previous chronic liver disease were excluded. The ACLF diagnosis was based on the European Association for the Study of the Liver-Chronic Liver Failure criteria and assessments repeated on days 3 and 7 after the initial diagnosis. Results: Among 381 patients, 10.49% (n = 40) were diagnosed with ACLF. Bacterial infection was the most common precipitating factor (45%). Kidney failure occurred in 65% of the cases. The 28-day mortality rate was 35% and varied according to ACLF severity at diagnosis, from single organ failure (ACLF-1) at 22% to three organ failures (ACLF-3) at 60%. Eighteen patients (45%) were transplanted with a 100% 28-day survival rate. For ACLF-3 cases at diagnosis (n = 15), the 28-day and 1-year survival rates with a transplant (n = 4) were 100% and 80%, respectively, and without transplant (n = 11), 10 and 0%, respectively. Conclusions: ACLF was associated with high mortality rates. LT was an effective therapeutic option, particularly for ACLF-3 cases.","PeriodicalId":6993,"journal":{"name":"Acta Cirúrgica Brasileira","volume":"53 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Cirúrgica Brasileira","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1590/acb392624","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

ABSTRACT Purpose: Acute-on-chronic liver failure (ACLF) is a leading cause of death in cirrhotic patients. This study aims to describe the outcomes of in-patients with ACLF at a liver transplantation (LT) center in Brazil. Methods: Retrospective study analyzing patient data from 2017 to 2022. Re-transplant cases and patients without previous chronic liver disease were excluded. The ACLF diagnosis was based on the European Association for the Study of the Liver-Chronic Liver Failure criteria and assessments repeated on days 3 and 7 after the initial diagnosis. Results: Among 381 patients, 10.49% (n = 40) were diagnosed with ACLF. Bacterial infection was the most common precipitating factor (45%). Kidney failure occurred in 65% of the cases. The 28-day mortality rate was 35% and varied according to ACLF severity at diagnosis, from single organ failure (ACLF-1) at 22% to three organ failures (ACLF-3) at 60%. Eighteen patients (45%) were transplanted with a 100% 28-day survival rate. For ACLF-3 cases at diagnosis (n = 15), the 28-day and 1-year survival rates with a transplant (n = 4) were 100% and 80%, respectively, and without transplant (n = 11), 10 and 0%, respectively. Conclusions: ACLF was associated with high mortality rates. LT was an effective therapeutic option, particularly for ACLF-3 cases.
急性慢性肝衰竭:巴西一家移植中心的病例回顾
ABSTRACT 目的:急性慢性肝功能衰竭(ACLF)是肝硬化患者死亡的主要原因。本研究旨在描述巴西一家肝移植(LT)中心的 ACLF 住院患者的治疗效果。方法:回顾性研究回顾性研究,分析2017年至2022年的患者数据。不包括再次移植病例和既往无慢性肝病的患者。ACLF 诊断基于欧洲肝脏研究协会-慢性肝衰竭标准,并在初次诊断后的第 3 天和第 7 天重复评估。结果在 381 名患者中,10.49%(n = 40)被诊断为 ACLF。细菌感染是最常见的诱发因素(45%)。65%的病例出现肾衰竭。28天的死亡率为35%,根据确诊时 ACLF 的严重程度而有所不同,从单一器官衰竭(ACLF-1)的22%到三个器官衰竭(ACLF-3)的60%不等。18名患者(45%)接受了移植手术,28天存活率为100%。对于确诊为 ACLF-3 的病例(n = 15),接受移植(n = 4)的 28 天和 1 年存活率分别为 100% 和 80%,未接受移植(n = 11)的 28 天和 1 年存活率分别为 10% 和 0%。结论ACLF 与高死亡率有关。LT是一种有效的治疗方案,尤其是对于ACLF-3病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信